Clinicians should be aware of the potential for persistent TIPN and its impact on patients' function and QOL. Future research should focus on large prospective studies with systematic TIPN assessments during and after treatment to better understand which symptoms and patient characteristics predict resolution. This information can guide treatment decisions, balancing the need for effective chemotherapy with minimizing long-term impairments in function and QOL.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- palliative care
- prognostic factors
- risk factors
- peritoneal dialysis
- case report
- healthcare
- high glucose
- oxidative stress
- radiation therapy
- diabetic rats
- locally advanced
- drug induced
- single molecule
- endothelial cells
- climate change
- sleep quality
- human health
- metastatic breast cancer